Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters
Why now
Thesis: Corporate footprint shift, no near-term earnings signal
Catalyst to watch: Details on investment size or pipeline programs
Main risk: Costs of relocation without disclosed returns
Why it matters
A pharma R&D and US HQ relocation concentrates research capacity near Boston's life-sciences cluster, but no financial terms or earnings impact are given.
Details
The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. The move is part of Lundbeck's continued investment in the US, a key market, and will support the company's Focused...
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-25 07:11 UTC
- prnewswire · 2026-09-25 07:06 UTC